H. Wong

发表

Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1

Stephen T C Wong, M. Ferrari, G. Jin, 2014, Stem cells.

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Jeffrey M. Rosen, Charles M. Perou, Susan G. Hilsenbeck, 2009, Proceedings of the National Academy of Sciences.

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models

Jenny C. Chang, W. Qian, R. Rosato, 2018, Breast Cancer Research.

A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.

Chad A Shaw, Gordon B Mills, Charles M Perou, 2013, Cancer research.

A gene transcription signature of obesity in breast cancer

C. Creighton, Jenny C. Chang, Yiqun Zhang, 2012, Breast Cancer Research and Treatment.

Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers.

S. Hilsenbeck, R. Schiff, Jenny C. Chang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer

Adrian V. Lee, P. O’Connell, C. Osborne, 2001, British Journal of Cancer.

Measuring natural killer cell cytotoxicity by flow cytometry.

E. Chan, H. Wong, Wai-Yu Wong, 2019, Pathology.

Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density

P. Brown, K. Hess, G. Hortobagyi, 2009, Breast Cancer Research and Treatment.

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

Susan G Hilsenbeck, Jeffrey Rosen, Jian Huang, 2008, Journal of the National Cancer Institute.

Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer

H. Grabsch, W. Greenhalf, Eithne Costello, 2010, Gut.

Identification and Mapping of a 2,009-bp DNA Deletion in SERPING1 of a Hereditary Angioedema Patient

E. Chan, H. Wong, E. Au, 2019, Case reports in genetics.

PI3 kinase activation and response to trastuzumab or lapatinib in HER-2 overexpressing locally advanced breast cancer (LABC).

R. Bernards, H. Horlings, Jenny C. Chang, 2009 .

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

Syed Mohsin, Susan G Hilsenbeck, Michael T Lewis, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapeutic resistance and tumor-initiation: Molecular pathways involved in breast cancer stem cell self-renewal

C. Creighton, Jenny C. Chang, C. Osborne, 2007 .

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models

Jenny C. Chang, W. Qian, R. Rosato, 2018, Breast Cancer Research.

Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors

Ian Krop, Jaya Paranilam, Max S Wicha, 2013, Clinical Cancer Research.

Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer

Jenny C. Chang, W. Qian, R. Rosato, 2018, Clinical Cancer Research.

ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer

Jenny C. Chang, W. Qian, A. Cohen, 2021, Breast Cancer Research and Treatment.

Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype

S. Hilsenbeck, P. O’Connell, Jenny C. Chang, 2006, Clinical Cancer Research.

HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway

Stephen T. C. Wong, O. Elemento, J. Sheng, 2017, Stem cell reports.

Role of RPL39 in Metaplastic Breast Cancer

O. Elemento, G. Mills, Jenny C. Chang, 2017, Journal of the National Cancer Institute.

Microfluidics separation reveals the stem-cell–like deformability of tumor-initiating cells

Lidong Qin, Dong Soon Choi, Weijia Zhang, 2012, Proceedings of the National Academy of Sciences.

Decrease in tumorigenic breast cancer stem cells – final results of a neoadjuvant trial in primary breast cancer patients

S. Hilsenbeck, C. Creighton, C. Osborne, 2008 .

Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases

G. Mills, Jenny C. Chang, F. Rojo, 2019, Breast Cancer Research and Treatment.

Cancer Therapy : Clinical Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors

Jenny C. Chang, G. Dontu, M. Wicha, 2013 .